RxDoctor Payments Data

Neha Patel, MD

Allergy & Immunology · Kansas City, MONPI 1184921421

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.9% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Abbott at 31.1% of the total. Reporting peaked in 2023 at $497 and has fallen 62.6% since, to $186 in 2025. That places this record below the midpoint for allergy & immunology clinicians in MO, where the typical reported total is $1,710.

$1,225in general payments, 2019–2025

Across 17 payments — averaging $72.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$381
  • Boston Scientific$289
  • Medtronic$105
  • Philips North America LLC$102
  • Regeneron Healthcare Solutions, Inc.$99
  • GSK$88
  • plus $160 from 3 others

What the payments were for

  • Food & beverage$1,12692%
  • Education$998%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,225 in reported general payments places this provider in the 40th percentile of 61 allergy & immunology providers in Missouri.

See all allergy & immunology providers in Missouri

Medicare billing

Part B allowed, 2024
$1,063,574
Medicare patients
220
Services billed
40,880

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$24,929
SymbicortBudesonide/Formoterol Fumarate18$7,086
Epinephrine26$3,770
Azelastine Hcl74$2,459
Montelukast Sodium221$1,571
Albuterol Sulfate HfaAlbuterol Sulfate22$741
Ipratropium Bromide23$603
Pantoprazole Sodium18$342
Famotidine15$338
Ketoconazole12$187
Levocetirizine Dihydrochloride24$172
Hydroxyzine Hcl13$170
Azithromycin17$169
Prednisone49$82

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$88$24,92932 claims
AstraZenecaSymbicort$84$7,08618 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 61 allergy & immunology providers in Missouri.

Other allergy & immunology in Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →